Ivantis To Pay $60M To End Patent Fight Over Glaucoma Tech
IP Law 360
SEPTEMBER 15, 2021
Glaukos Corp. have inked a $60 million deal to end their patent dispute over therapies for treating glaucoma, the companies announced Wednesday. and Ivantis Inc.
Let's personalize your content